All That Glitters: Sorafenib

被引：3
作者：
Abbass, Khurram [1 ,2 ]
Dewani, Shabana [1 ,2 ]
Markert, Ronald [2 ]
Kaplon, Michael K. [1 ,2 ]
Baumann, Michael A. [1 ,2 ]
机构：
[1] Dayton Vet Affairs Med Ctr, Dayton, OH USA
[2] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA
来源：
INTERNAL MEDICINE | 2011年 / 50卷 / 07期
关键词：
sorafenib; tumor lysis syndrome; hepatocellular carcinoma; TUMOR LYSIS SYNDROME; HEPATOCELLULAR-CARCINOMA; PATIENT;
D O I：
10.2169/internalmedicine.50.4858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：797 / 797
页数：1
相关论文
共 3 条
  • [1] Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient
    Huang, Wu-Shiung
    Yang, Chang-Hsu
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (35) : 4464 - 4466
  • [2] A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
    Joshita, Satoru
    Yoshizawa, Kaname
    Sano, Kenji
    Kobayashi, Satoshi
    Sekiguchi, Tomohiro
    Morita, Susumu
    Kamijo, Atsushi
    Komatsu, Michiharu
    Umemura, Takeji
    Ichijo, Tetsuya
    Matsumoto, Akihiro
    Tanaka, Eiji
    [J]. INTERNAL MEDICINE, 2010, 49 (11) : 991 - 994
  • [3] Shiozawa K, 2010, HEPATO-GASTROENTEROL, V57, P688
1